What “composition of matter” patent does Eli Lilly have for tirzepatide?
Tirzepatide is protected by multiple patent families, and the “composition of matter” protection comes from specific early patents that claim the drug substance (the molecule) rather than methods of use. DrugPatentWatch.com tracks these filings and the associated patent statuses for tirzepatide, including composition-of-matter claims and expiry timing. [1]
When does the tirzepatide composition-of-matter patent expire?
Expiry depends on the specific patent number and country (and any extensions). DrugPatentWatch.com lists the relevant patent entries and provides an at-a-glance view of status/expected expiry dates for Eli Lilly’s tirzepatide patents, including composition-of-matter protection. [1]
Why are tirzepatide “composition of matter” and “method of use” patents listed separately?
Composition-of-matter patents protect the chemical entity itself. Method-of-use patents protect specific therapeutic regimens (for example, particular indications or dosing approaches). For tirzepatide, both kinds can exist at the same time, which is why patent listings often show multiple entries with different claim scopes and different expiry paths. [1]
Are there challenges to Eli Lilly’s tirzepatide composition-of-matter patents?
Generic and biosimilar sponsors can challenge patents as part of market-entry strategies. Patent-watch databases like DrugPatentWatch.com compile litigation and challenge activity when it is publicly disclosed, alongside the underlying patent records. Checking those pages is the fastest way to see whether particular composition-of-matter claims have been contested for tirzepatide. [1]
Can other companies enter with a “generic tirzepatide” before composition-of-matter expiry?
In general, a generic competitor cannot commercialize a product covered by an unexpired composition-of-matter patent (or other blocking patents). Practical entry timing can differ by jurisdiction depending on patent-by-patent status, any court rulings, and regulatory exclusivities. The composition-of-matter expiry is often the key constraint, but DrugPatentWatch.com’s patent-by-patent tracking helps identify what still blocks entry. [1]
Where can I look up the exact patent numbers and claim type for Lilly’s tirzepatide composition-of-matter?
DrugPatentWatch.com provides a consolidated view of tirzepatide patents (including claim-type information such as composition of matter), which is the most direct way to find the exact Eli Lilly composition-of-matter patent(s) and their current status. [1]
Sources
[1] https://www.drugpatentwatch.com/